Enveric Biosciences Announces Exercise of Warrants for $3.1 Million Gross Proceeds Life Science Investing
Republic Technologies Doubles ETH Holdings Amid 23% Appreciation in Total Value Medical Device Investing
PTC's Windchill+ Powering HOLON's Development of One of the World's First Automotive-Standard Level-4 EVs Life Science Investing
OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain Life Science Investing
RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026 Life Science Investing
Guardant Health Announces Collaboration with Trial Library to Increase Access to Cancer Clinical Trials Across the U.S. Life Science Investing
Charles River Extends Commitment to Advanced Therapy Developers with Second Incubator Program Cohort Life Science Investing
BeyondSpring Announces New Analyses of DUBLIN-3 Phase 3 Study Showing Survival Benefit of Plinabulin + Docetaxel in Post Anti-PD-1 for Non-squamous EGFR WT NSCLC and a Reduction in Brain Metastasis Compared to Docetaxel at NACLC 2025 Life Science Investing
